Back to Search
Start Over
Atorvastatin and diacerein reduce insulin resistance and increase disease tolerance in rats with sepsis
- Source :
- Journal of Inflammation, Vol 15, Iss 1, Pp 1-11 (2018), Scopus, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP, Journal of Inflammation (London, England)
- Publication Year :
- 2018
- Publisher :
- Springer Science and Business Media LLC, 2018.
-
Abstract
- Made available in DSpace on 2018-12-11T16:53:11Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-05-09 Background: Sepsis is one of the leading causes of death among hospitalized patients. At the onset of this condition, there is an over-production of pro-inflammatory mediators that contribute to organ failure and death. The excess production of pro-inflammatory mediators also impairs insulin signaling, which may be a pathophysiological tissue marker of proinflammatory cytokine action before organ failure. Statins and diacerein have pleiotropic effects, such as the blockage of inflammatory signaling pathways, suggesting that these drugs may be an attractive therapeutic or prophylactic strategy against sepsis. The aim of the present study was to investigate whether a statin or diacerein can improve insulin signaling, disease tolerance and survival in sepsis by inhibiting inflammatory pathways. Methods: We investigated the effect of these drugs on survival, tissue insulin signaling and inflammatory pathways in the liver and muscle of rats with sepsis induced by cecal ligation and puncture (CLP). Results: The results showed that administration of medications, with anti-inflammatory ability, to septic animals increased survival and improved disease tolerance and insulin resistance in the liver and muscle. The treatment also attenuated ER stress, NF-κB, JNK activation and restored glucose-6-phosphatase (G6Pase) levels in the liver. Conclusions: Our results indicate that atorvastatin and diacerein treatment can modulate inflammatory pathways and, in parallel, attenuate insulin resistance in sepsis. Since these two drugs have safety profiles and minimal side effects, we suggest that these drugs may be alternative therapies for the prevention or therapies for the treatment of insulin resistance in sepsis, which could potentially reduce mortality in patients with sepsis. Department of Internal Medicine State University of Campinas Department of Biology Science Federal University of Pernambuco Department of Physical Education São Paulo State University (UNESP) Bioscience Institute Departamento de Clínica Médica FCM-UNICAMP Cidade Universitária Zeferino Vaz Department of Physical Education São Paulo State University (UNESP) Bioscience Institute
- Subjects :
- Diacerein
0301 basic medicine
Statin
medicine.drug_class
Atorvastatin
Clinical Biochemistry
Pharmacology
Proinflammatory cytokine
Sepsis
03 medical and health sciences
Insulin resistance
medicine
biology
business.industry
Research
lcsh:RM1-950
Cell Biology
medicine.disease
Pathophysiology
Insulin receptor
lcsh:Therapeutics. Pharmacology
030104 developmental biology
biology.protein
business
medicine.drug
Subjects
Details
- ISSN :
- 14769255
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Journal of Inflammation
- Accession number :
- edsair.doi.dedup.....9d94a5afe4542153670215bb0ee442b2
- Full Text :
- https://doi.org/10.1186/s12950-018-0184-9